These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6179635)

  • 61. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis.
    Waxman FJ; Fritz RB; Hinrichs DJ
    Cell Immunol; 1980 Jan; 49(1):34-42. PubMed ID: 6153156
    [No Abstract]   [Full Text] [Related]  

  • 64. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental allergic encephalomyelitis in hamsters.
    Paterson PY; Drobish DG; Massanari MR
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):161-7. PubMed ID: 4204827
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of lymphocyte subpopulations in the transfer of rat EAE.
    Brostoff SW; Mason DW
    J Neuroimmunol; 1986 Feb; 10(4):331-40. PubMed ID: 2418055
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
    Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
    Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
    [No Abstract]   [Full Text] [Related]  

  • 69. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis.
    Offner H; Jones R; Vandenbark AA
    Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830
    [No Abstract]   [Full Text] [Related]  

  • 70. The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis.
    Mokhtarian F; Shirazian T; Batuman O; Shi Y
    Ann N Y Acad Sci; 1996 Feb; 778():414-7. PubMed ID: 8611007
    [No Abstract]   [Full Text] [Related]  

  • 71. Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis.
    Lemire JM; Weigle WO
    Pathol Immunopathol Res; 1986; 5(3-5):248-52. PubMed ID: 2440016
    [No Abstract]   [Full Text] [Related]  

  • 72. Adoptive transfer of experimental allergic encephalomyelitis with lectin-activated spleen cells. Part 2. Studies on T cell subsets and interleukin 2 production.
    Takenaka A; Minagawa H; Kaneko K; Mori R; Itoyama Y
    J Neurol Sci; 1986 Feb; 72(2-3):337-45. PubMed ID: 3486946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis.
    Seil FJ; Smith ME; Leiman AL; Kelly JM
    Science; 1975 Mar; 187(4180):951-3. PubMed ID: 49925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Direct cell-mediated cytotoxicity in experimental allergic encephalomyelitis.
    Eggers AE; Hibbard CA
    J Neurol Sci; 1981 Jan; 49(1):109-16. PubMed ID: 6162919
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease.
    Sun D; Whitaker JN; Wilson DB
    Int Immunol; 1999 Mar; 11(3):307-15. PubMed ID: 10221642
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
    Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
    J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.